Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rachel Humphrey Insider Profile
11 Followers
Rachel Humphrey, EVP and Chief Medical Officer at Mirati Therapeutics, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 96.81K shares in Pyxis Oncology (Ticker: PYXS), holds 10.00K shares in Black Diamond Therapeutics (Ticker: BDTX). Most recently, Rachel Humphrey ― shares of Mirati Therapeutics on ― for an estimated value of ―.
Rachel Humphrey Mirati Therapeutics (MRTX)EVP and Chief Medical Officer
Mirati Therapeutics (MRTX)
EVP and Chief Medical Officer
Not Ranked
Rachel Humphrey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rachel Humphrey holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Rachel Humphrey
Rachel Humphrey's Trading History
Mirati Therapeutics
―
―
―
$0.00
CytomX Therapeutics
Mar 05, 2018
CMO
Uninformative Buy
106.82K
$32.96K
Black Diamond Therapeutics
Sep 10, 2020
CMO
Uninformative Buy
―
$22.20K
Pyxis Oncology
Mar 28, 2024
Director
Uninformative Buy
―
$163.60K
List of latest transactions for each holding click on a transaction to see Rachel Humphrey's performance on stock
You May Also Like
Rachel Humphrey insider profile FAQ
What is the percentage of profitable transactions made by Rachel Humphrey?
The percentage of profitable transactions made by Rachel Humphrey is ―.
What is the average return per transaction made by Rachel Humphrey?
The average return per transaction made by Rachel Humphrey is ―.
What stocks does Rachel Humphrey hold?
Rachel Humphrey holds: MRTX, CTMX, BDTX, PYXS stocks.
What was Rachel Humphrey’s latest transaction?
Rachel Humphrey latest transaction was an Uninformative Buy of ―.
What was Rachel Humphrey's most profitable transaction?
Rachel Humphrey’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Rachel Humphrey's role in Mirati Therapeutics?
Rachel Humphrey's role in Mirati Therapeutics is EVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.